Amicus Therapeutics, Inc.
(NASDAQ : FOLD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.56%190.481.2%$558.09m
GILDGilead Sciences, Inc.
-0.38%70.650.9%$493.86m
BIIBBiogen Inc.
-1.56%314.101.3%$441.56m
CELGCelgene Corporation
-1.04%69.511.2%$414.06m
ILMNIllumina, Inc.
-0.97%308.153.5%$394.41m
REGNRegeneron Pharmaceuticals, Inc.
-1.62%336.572.6%$277.22m
VRTXVertex Pharmaceuticals Incorporated
-3.73%163.961.9%$261.23m
ALXNAlexion Pharmaceuticals, Inc.
-1.92%116.242.0%$195.24m
AAgilent Technologies, Inc.
-1.22%63.561.5%$166.10m
EXASExact Sciences Corporation
-2.01%68.0225.3%$146.66m
LGNDLigand Pharmaceuticals Incorporated
-0.28%148.0123.3%$143.20m
SRPTSarepta Therapeutics, Inc.
-4.88%111.0716.4%$127.06m
ECYTEndocyte, Inc.
-0.11%23.562.0%$120.16m
INCYIncyte Corporation
-0.11%63.662.5%$112.27m
NKTRNektar Therapeutics
1.77%38.015.6%$107.73m

Company Profile

Amicus Therapeutics, Inc. is a biotechnology company, which is engaged in the discovery, development and commercialization of novel treatments for patients living with rare and orphan diseases. Its product include migalastat HCl, which is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy for fabry disease. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ.